Athersys to Host Year-End 2019 Financial Results Call
CLEVELAND--(BUSINESS WIRE)--Feb 10, 2020--
Athersys, Inc. (Nasdaq: ATHX) will release its year-end 2019 financial results at approximately 4:00 PM Eastern Time on Monday, March 16, 2020, and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results. Members of the management team will host the call as follows:
March 16, 2020
4:30 p.m. (Eastern Time)
Telephone access: US and Canada
Telephone access: International
Encore Passcode (needed for the replay only)
We encourage shareholders to listen using the webcast link, and to use the phone line if you intend to ask a question. A replay will be available on the webcast link at www.athersys.com under the investors section approximately three hours after the call has ended. Shareholders may also call in for on-demand listening shortly after the completion of the call until 11:59 PM Eastern Time on March 21, 2020 by dialing (800) 585-8367 or (416) 621-4642 and entering the conference code 9937937.
Athersys is a biotechnology company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem ® cell therapy product, a patented, adult-derived “off-the-shelf” stem cell product, initially for disease indications in the neurological, inflammatory and immune, cardiovascular and other critical care indications and has several ongoing clinical trials evaluating this potential regenerative medicine product. Athersys has forged strategic partnerships and a broad network of collaborations to further advance the MultiStem cell therapy toward commercialization. More information is available at www.athersys.com. Follow Athersys on Twitter at www.twitter.com/athersys.
View source version on businesswire.com:https://www.businesswire.com/news/home/20200210005117/en/
CONTACT: William (B.J.) Lehmann, J.D.
President and Chief Operating Officer
Tel: (216) 431-9900
Director of Corporate Communications and Investor Relations
Tel: (216) 431-9900
Russo Partners, LLC
Tel: (212) 845-4271 or (858) 717-2310
KEYWORD: OHIO UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: CARDIOLOGY STEM CELLS BIOTECHNOLOGY OTHER HEALTH HEALTH GENERAL HEALTH PHARMACEUTICAL OTHER SCIENCE RESEARCH HOSPITALS SCIENCE
SOURCE: Athersys, Inc.
Copyright Business Wire 2020.
PUB: 02/10/2020 08:00 AM/DISC: 02/10/2020 08:01 AM